MedTrace Logo

Acceptability of Hepatitis B Vaccination in General Population

NCT01782794 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2413

Last updated 2013-02-04

No results posted yet for this study

Summary

The present study is conducted in order to assess the acceptability of Hepatitis B vaccination in French general population before and after reimbursement of the paediatric vaccine InfanrixHexa. Four measurements are planned, first before reimbursement and the others at year 1, 2 and 3 after reimbursement.

Conditions

Interventions

OTHER

Data collection

Poll and questionnaire-based methodology completed by face-to-face interviews, with possible additional follow-up offered to households.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
12 Months
Max Age
27 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-06-30
Completion
2012-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01782794 on ClinicalTrials.gov